1. Home
  2. AAPG vs ADUS Comparison

AAPG vs ADUS Comparison

Compare AAPG & ADUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AAPG
  • ADUS
  • Stock Information
  • Founded
  • AAPG 2009
  • ADUS 1979
  • Country
  • AAPG China
  • ADUS United States
  • Employees
  • AAPG N/A
  • ADUS N/A
  • Industry
  • AAPG Biotechnology: Pharmaceutical Preparations
  • ADUS Medical/Nursing Services
  • Sector
  • AAPG Health Care
  • ADUS Health Care
  • Exchange
  • AAPG Nasdaq
  • ADUS Nasdaq
  • Market Cap
  • AAPG 2.2B
  • ADUS 1.8B
  • IPO Year
  • AAPG 2025
  • ADUS 2009
  • Fundamental
  • Price
  • AAPG $24.40
  • ADUS $110.91
  • Analyst Decision
  • AAPG Buy
  • ADUS Buy
  • Analyst Count
  • AAPG 1
  • ADUS 10
  • Target Price
  • AAPG N/A
  • ADUS $143.50
  • AVG Volume (30 Days)
  • AAPG 14.1K
  • ADUS 179.2K
  • Earning Date
  • AAPG 06-10-2025
  • ADUS 05-05-2025
  • Dividend Yield
  • AAPG N/A
  • ADUS N/A
  • EPS Growth
  • AAPG N/A
  • ADUS 9.84
  • EPS
  • AAPG N/A
  • ADUS 4.42
  • Revenue
  • AAPG $134,352,180.00
  • ADUS $1,211,561,000.00
  • Revenue This Year
  • AAPG N/A
  • ADUS $23.33
  • Revenue Next Year
  • AAPG $389.09
  • ADUS $5.69
  • P/E Ratio
  • AAPG N/A
  • ADUS $25.12
  • Revenue Growth
  • AAPG 341.77
  • ADUS 11.38
  • 52 Week Low
  • AAPG $16.50
  • ADUS $88.96
  • 52 Week High
  • AAPG $26.55
  • ADUS $136.72
  • Technical
  • Relative Strength Index (RSI)
  • AAPG N/A
  • ADUS 55.13
  • Support Level
  • AAPG N/A
  • ADUS $108.46
  • Resistance Level
  • AAPG N/A
  • ADUS $115.94
  • Average True Range (ATR)
  • AAPG 0.00
  • ADUS 3.08
  • MACD
  • AAPG 0.00
  • ADUS -0.19
  • Stochastic Oscillator
  • AAPG 0.00
  • ADUS 41.31

About AAPG Ascentage Pharma Group International American Depository Shares

Ascentage Pharma Group International is a clinical-stage biotechnology company engaged in the development and sales of novel small-scale therapies for cancers, hepatitis B virus, or HBV, and certain age-related diseases. It focuses on developing therapies that inhibit protein-protein interactions to restore apoptosis or programmed cell death. The Group has one reportable operating segment, which is discovering, developing, and commercializing therapies to address medical needs in hematological malignancies. The company's geographical segments include the United States and Mainland China.

About ADUS Addus HomeCare Corporation

Addus HomeCare Corp is engaged in the provision of in-home personal care services. It operates through the segments such as Personal care segment, which is a key revenue driver, provides non-medical assistance with activities of daily living, primarily to persons who are at risk of hospitalization or institutionalization, such as the elderly, chronically ill and disabled. The Hospice segment provides physical, emotional and spiritual care for people who are terminally ill and their families. Its Home health segment provides services that are primarily medical in nature to those individuals who may require assistance during an illness or after surgery.

Share on Social Networks: